The global interventional cardiology devices market size is expected to reach USD 22.35 billion by 2030, according to a new report by Grand View Research Inc. The market is expected to expand at a CAGR of 7.2% from 2023 to 2030 Demand for interventional cardiology devices is on the rise owing to favorable reimbursement policies for coronary intervention procedures, rising prevalence of cardiovascular diseases (CVDs) and diabetes across the globe, and the launch of new product lines in the market. Cardiovascular diseases have become one of the major causes of mortality and morbidity in the world. Coronary artery disease and congenital heart defects are the major cardiovascular diseases that are prevalent across the globe. 

Furthermore, the adoption of unhealthy lifestyles, such as smoking, a sedentary lifestyle, and improper diet, is responsible for diabetes. Cardiac catheterization, angioplasty, and Percutaneous Coronary Intervention (PCI) are some of the major procedures used for the treatment of cardiovascular diseases. Since diabetes is one of the major reasons behind triggering cardiovascular diseases, increasing diabetes cases are expected to surge the demand for interventional cardiology devices over the forecast period. Although the market is anticipated to expand over the coming years, it might witness slower growth possibly brought on by the high price of medical devices, especially in developing economies with insufficient insurance coverage.

Gather more insights about the market drivers, restrains and growth of the Interventional Cardiology Devices Market

Interventional Cardiology Devices Market Report Highlights

• The coronary stents segment dominated the market with the largest revenue share of 64.6% in 2022. DES makes up the majority of sales in the coronary stent category.

• Technological advancements in coronary stents, such as the development of bifurcated stents and the use of biodegradable materials, have led to efficient and improved outcomes of CVD treatment. Companies are proactively involved in product developments and partnerships and strategic collaborations. The aforementioned factors are expected to propel industry growth over the forecast period

• Asia Pacific region is expected to advance at the fastest CAGR of 7.9% over the forecast period. This growth can be attributed to several factors, including the increasing incidence of coronary artery disease (CAD) and improved screening measures for this disorder.

• The market is fragmented due to the presence of several players. This is expected to intensify the competition in the coming years. Market players are adopting various strategic initiatives such as partnerships, sales & marketing activities, mergers & acquisitions, service expansion, integrated offerings, and product launches to increase their market presence 

Interventional Cardiology Devices Market Segmentation

Grand View Research has segmented the global interventional cardiology devices market report based on product and region:

Interventional Cardiology Devices Product Outlook (Revenue, USD Million, 2018 - 2030)

• Coronary Stents

o DES

o BMS

o BRS

• PTCA Balloon Catheters

o Normal

o Specialty (Includes cutting, scoring, and lithotripsy balloons)

o DCB

• Accessory Devices

o PTCA Guidewires (Workhorse, Specialty)

o Diagnostic Catheters

o PTCA Guiding Catheters

o Introducer Sheaths

• Intravascular Imaging Catheters and Pressure Guidewires (IVUS Catheters, OCT Catheters, FFR Guidewires)

Interventional Cardiology Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o UK

o Germany

o France

o Italy

o Spain

o Denmark

o Sweden

o Norway

• Asia Pacific

o Japan

o China

o India

o Australia

o Thailand

o South Korea

• Latin America

o Brazil

o Mexico

o Argentina

• Middle East & Africa

o South Africa

o Saudi Arabia

o UAE

o Kuwait

• Middle East & Africa

Order a free sample PDF of the Interventional Cardiology Devices Market Intelligence Study, published by Grand View Research.